CRVS Short Positions, Funds Shorting Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US2210151005

Pengekort Corvus Pharmaceuticals, Inc.

Denne side viser institutioner, fonde og større aktionærer, der har rapporteret korte positioner i deres seneste rapporteringsperiode. Vi betragter put-optionspositioner som korte positioner og inkluderer alle institutter, der har oplyst put-optioner her. Grønne rækker angiver nye positioner. Røde rækker angiver lukkede positioner. Klik på linkikonet for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2025-08-14 13F Group One Trading, L.p. Put 14.700 -77,99 59 -72,64
2025-08-14 13F Jane Street Group, Llc Put 0 -100,00 0
2025-08-12 13F Proequities, Inc. Put 0 0
2025-08-14 13F Citadel Advisors Llc Put 38.200 -63,51 153 -54,22
2025-05-15 13F ADAR1 Capital Management, LLC Put 0 -100,00 0 -100,00
2025-05-15 13F LMR Partners LLP Put 0 -100,00 0 -100,00
2025-08-14 13F B Group, Inc. Put 0 -100,00 0 -100,00
2025-08-18 13F Wolverine Trading, Llc Put 10.500 -21,05 41 -9,09
2025-08-14 13F Ikarian Capital, LLC Put 0 -100,00 0
2025-08-14 13F Millennium Management Llc Put 150.000 200,00 600 277,36
2025-08-05 13F Simplex Trading, Llc Put 12.000 -89,27 0
2025-08-14 13F Boothbay Fund Management, Llc Put 0 -100,00 0
2025-08-14 13F Susquehanna International Group, Llp Put 27.400 -70,60 110 -63,18
Other Listings
DE:C17 5,04 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista